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/l. BM examination supported a diagnosis of very severe aplastic anemia. Tests for chromosomal fragility and paroxysmal nocturnal hemoglobinuria were negative. An extended family search did not reveal a matched donor, so IST with thymoglobulin (2.5 mg/kg/day for 5 days) and CsA (3 mg/kg) was started. Multiple (420) transfusions of plts and RBCs were given. The patient's mother was at this time in her 32nd week of pregnancy.
Serum sickness developed after rabbit ATG, managed with methylprednisolone (2 mg/kg). Shortly after initiation of IST, facial swelling and sero-sanguinous nasal discharge appeared. Computerized tomography revealed pansinusitis with evidence of bony destruction. Biopsy and culture revealed angioinvasive fungi with non-septate broad-based hyphae consistent with Mucor.
Antifungal treatment with amphotericine-B and posaconazol were started with clinical and radiographic stabilization of invasive mycosis. Additionally, the child developed polymicrobial sepsis, which was managed with antibiotics. Two months after beginning IST, the patient's mother gave birth. Umbilical cord blood (UCB) was found to be HLA matched; total number of nucleated cells in the sample was 3.8 Â 10 7 /kg of patient's body weight. Compromised condition (Lansky score 40%), progressive mucormycosis and recurrent sepsis made HSCT urgent. However, the prolonged aplasia usually associated with UCB transplantations imparted a particularly high risk of death. We therefore decided to enrich the UCB unit with BM collected from the neonate. Harvesting of 80 ml of BM was done from both tibiae at donor age 2 months (weight 4 kg), providing an additional total number of nucleated cells 7.7 Â 10 7 /kg with CD34 6.9 Â 10 6 /kg and CD3 þ 2.3 Â 10 6 / kg (recipient weight). Collection was uneventful, without significant decrease in Hb levels (from 12 to 10 g per 100 ml).
Pretransplant conditioning consisted of previously described fludarabine 180 mg/kg, CY 120 mg/kg and horse ATG (Atgam) 60 mg/kg with CsA for GVHD prophylaxis.
ANC engrafted (40.5 Â 10 9 /l) on day þ 16 and plts (420 Â 10 9 /l) on day þ 20. Throughout, the patient continued treatment with posaconazole. On day þ 10 he developed fever. Blood cultures grew Enterobacter cloacae and coagulase negative Staphylococcus, which responded to empiric antibiotics. On day þ 15 localized pain in the right proximal forearm developed X-rays suggested right proximal ulnar osteomyelitis, which resolved after 6 weeks of antibiotic treatment. Now, 6 months after allo-HSCT, the child is well with 100% donor engraftment, no evidence of GVHD after stopping CsA and no evidence of recurrence of mucormycosis. His donor is in good health and developing normally.
We may derive several lessons from this case. Mold infections are often lethal in neutropenic patients with hematological malignancies, solid tumors or BM failure syndromes. In the HSCT setting, where recovery of neutrophil count is crucial, mortality can reach 80%. 2 Classical approaches consisted of surgical debridement and use of Amphotericin B, but newer approaches with endoscopic surgery offer less traumatic management. 3 Several recent studies show that posaconazole is a suitable oral treatment for mucormycosis and that surgical intervention is not always necessary; our case provides additional support for this position. 4, 5 Hematopoietic SCT is the treatment of choice for children with SAA who have an HLA-matched sibling donor. The main factors influencing survival are high number of blood transfusions, prior IST and pretransplant infections. [6] [7] [8] In our case, the patient suffered from several proven bacterial infections as well as invasive rhinocerebral mucormycosis. To shorten the prolonged chemotherapy induced aplasia typically seen in UCB transplantation, we combined UCB with BM from the same donor. This combination resulted in a fairly rapid granulocyte engraftment, likely making a significant impact on outcome.
In the few case reports regarding combined cord and BMT, donor age has been reported to be at least 18 months. 9 To our knowledge, we report the youngest donor for combined cord and BMT to date. BM harvesting was uneventful with a high amount of nucleated cells and CD34, and relatively low proportion of CD3 þ cells, illustrating the feasibility of transplantation from small baby donors when indicated.
